Encompass Health (NYSE: EHC) CEO logs tax-withholding share dispositions

Rhea-AI Filing Summary

Encompass Health Corp President & CEO Mark J. Tarr reported two tax-related share dispositions of Encompass Health common stock. On February 19, 43,378 shares were withheld at $107.15 per share, and on February 20, 1,797 shares were withheld at $106.55 per share.

According to the disclosure, these shares were withheld or surrendered to cover tax withholding obligations tied to the vesting of restricted stock, rather than open-market sales. After these transactions, Tarr directly owned 445,637 Encompass Health shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Tarr Mark J

Role President & CEO

Type	Security	Shares	Price	Value
Tax Withholding	Encompass Health Common Stock	1,797	$106.55	$191K
Tax Withholding	Encompass Health Common Stock	43,378	$107.15	$4.65M

Holdings After Transaction: Encompass Health Common Stock — 445,637 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tarr Mark J

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/19/2026		F		43,378(1)	D	$107.15	447,434	D
Encompass Health Common Stock	02/20/2026		F		1,797(1)	D	$106.55	445,637	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

	/s/ Patrick Darby, attorney-in-fact for Mark J. Tarr	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Encompass Health (EHC) CEO Mark Tarr report?

Mark Tarr reported two tax-related share dispositions. On February 19, 43,378 shares were withheld at $107.15, and on February 20, 1,797 shares were withheld at $106.55, all to satisfy tax obligations from restricted stock vesting.

Were Mark Tarr’s Encompass Health (EHC) transactions open-market stock sales?

No, the transactions were not open-market sales. The filing states the shares were withheld or surrendered solely to cover Tarr’s tax withholding obligations arising from the vesting of related restricted stock awards, a common administrative mechanism.

How many Encompass Health (EHC) shares does CEO Mark Tarr own after these transactions?

After the reported tax-withholding dispositions, Mark Tarr directly owns 445,637 shares of Encompass Health common stock. This figure reflects his remaining direct holdings following the share withholdings tied to vested restricted stock awards disclosed in the filing.

What is the transaction code used in Mark Tarr’s Encompass Health (EHC) Form 4?

Both transactions use code F, defined as payment of an exercise price or tax liability by delivering securities. Here it specifically reflects shares withheld or surrendered to satisfy income tax withholding on vested restricted stock, not discretionary buying or selling.

On what dates did Encompass Health (EHC) CEO Mark Tarr’s tax-withholding transactions occur?

The tax-withholding transactions occurred on two consecutive days. One was dated February 19 and involved 43,378 shares, and the second was dated February 20 involving 1,797 shares, both in Encompass Health common stock, as reported in the Form 4.